摘要
交感传出和前列腺素(PGs)在周围神经不全损伤和炎症所引起的痛过敏中起重要作用,它们对糖尿病性痛过敏的影响尚不清楚。本工作先给大鼠腹腔注射6-羟多巴胺(6-OHDA)损毁交感节后神经元(SPGNS)末梢后,再给予链脲佐菌素(STZ)以建立6-OHDA糖尿病大鼠模型,在连续4周的观察中这组大鼠伤害性爪回缩阈值(NPWT)和甩尾反射潜伏期(TFL)没有明显变化,而糖尿病组大鼠的痛阈显著降低,并伴有痛过敏。皮内注射NA可使糖尿病痛过敏大鼠的NPWT显著降低,酚妥拉明或育亨宾能使它们的NPWT明显升高,而哌唑嗪则不影响其NPWT。去甲肾上腺素(NA)和酚妥拉明不影响对照组大鼠的NPWT。给6-OHDA糖尿病组大鼠皮内注射NA或酚妥拉明都不能明显改变大鼠的NPWT。PGE1,PGE2和PGD2能使对照组和糖尿病组大鼠的NPWT均明显降低、结果提示,SPGNs末梢参与糖尿病大鼠的痛过敏,NA作用于SPGNs末梢的突触前α2-受体,刺激SPGNs末梢合成和释放PGs增多,后者作用于初级传入伤害感受器,引起大鼠产生痛过敏。
While sympathetic efferents and prostaglandins (PGs) play an important role inhyperalgesia of partial injury of peripheral nerves and inflammation, whether these arealso involved in diabetic hyperalgesia is unknown. With intraperitoneal injection of 6-hydroxydopamine (6-OHDA) to eliminate effects of sympathetic postganglionic neurons (SPGNs) terminals, a model of diabetic rats with infused 6-OHDA could be set upby injection of streptozotocin (STZ). Nociceptive paw-withdrawal threshold (NPWT)and tail flick latency (TFL) in 6-OHDA/diabetic rats were not changed significantly inthe following four weeks. However, in diabetic group rats, pain threshold was decreased significantly and accompanied by development of hyperalgesia. NPWT was significantly decreased with noradrenaline (NA) in diabetic hyperalgesic rats and increased with phentolamine or yohimbine, but not by prazocin. In the control rats,NPWT are not changed significantly by NA or phentolamine, and in 6-OHDA/diabeticrats, neither NA nor phentolamine also affected on NPWT significantly. However,NPWT may be significantly decreased by PGEI, PGE2 and PGD2 in both the controland the diabetic hyperalgesic rats. The above results suggested that SPGNs terminals areinvolved in hyperalgesia of diabetic rats, NA accelerated synthesis of PGs and releasedby way of presynaptic effect on a2-adrenergic receptors at the SPGNs terminals, PGs,in turn, directly acted on the primary afferent nociceptors, producing hyperalgesia.
出处
《生理学报》
CAS
CSCD
北大核心
1996年第6期536-542,共7页
Acta Physiologica Sinica
关键词
糖尿病
交感传出
痛过敏
sympathetic efferent
prostaglandins
diabetes
hyperalgesia
rat